Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia · Delayed Price · Currency is AUD 0.2450
0.00 (0.00%)
Sep 18, 2026, 4:10 PM AEST
ASX:PAR Market Cap
ASX:PAR has a market cap or net worth of 146.8 million as of October 1, 2026. Its market cap has increased by 27.32% in one year.
Market Cap
146.80M
Enterprise Value
138.87M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.25
ChartMarket Cap Chart
Since August 19, 2015, ASX:PAR's market cap has increased from 32.40M to 146.80M, an increase of 353.03%. That is a compound annual growth rate of 14.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 146.80M | 0.76% |
| Dec 31, 2025 | 145.70M | -0.23% |
| Dec 31, 2024 | 146.04M | -2.24% |
| Dec 29, 2023 | 149.39M | -62.33% |
| Dec 30, 2022 | 396.54M | -8.38% |
| Dec 31, 2021 | 432.81M | -25.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Actinogen Medical | 230.87M |
| BLS Pharmaceuticals | 229.15M |
| Orthocell | 202.89M |
| Dimerix | 138.09M |
| Island Pharmaceuticals | 116.89M |
| Nyrada | 115.13M |
| Recce Pharmaceuticals | 99.38M |
| Alterity Therapeutics | 88.28M |